Franklin Resources heads into its fiscal Q3 earnings today with short sellers in retreat and options traders showing no urgency — a calm setup that has shifted marginally since the last preview, with SI ticking higher and availability loosening further.
Short interest has edged back up since the July 27 preview, rising to roughly 3.95% of the free float from the 3.7% flagged then. That partial rebuild — about 1.1 million additional shares shorted over the week — reverses some of the retreat from June's peak near 23 million shares, though the overall picture remains well off that high. The borrow market tells a consistent story: cost to borrow is running at just under 0.50%, barely changed over the month, and availability has expanded further to over 1,000% — meaning approximately ten shares are available to lend for every one currently borrowed. That is actually looser than the already-loose conditions described a few days ago, and well above the 52-week trough near 355%. The lending pool is not signalling fresh bearish conviction.
Options positioning has also shifted only marginally. The put/call ratio is 0.51, fractionally above its 20-day average of 0.50, with a z-score of just 0.52. That places it almost exactly in neutral territory — nowhere near the defensive positioning that would suggest investors are bracing for a miss. The 52-week range for the PCR runs from 0.30 to 1.04, so the current reading is well within the lower half. The stock itself has added about 2.7% on the week to $33.17, roughly in line with peers: rose 3.4% on the day, gained 4.9%, and added 4.8%, though has been the standout of the group, up nearly 6% on the week.
The analyst community has been lifting targets steadily but keeping ratings flat. Barclays raised its target to $34 from $31 in mid-July while holding Equal-Weight. Evercore ISI also moved its target higher — to $35 — while maintaining its Underperform. Those moves followed a string of upgrades and raises after the April print, when Morgan Stanley upgraded from Underweight and Goldman Sachs lifted its target to $34. The consensus mean target is $34.45, a modest premium to the current price. The bull case rests on improving AUM momentum and the stock's exceptionally high dividend score — ranked in the 98th percentile — while bears point to structural outflows from active management, integration drag, and a short score sitting near the middle of the range at 47. Valuation gives neither side an obvious edge: the P/E is running around 10.9x with the EV/EBITDA near 7.4x and drifting lower over the past month.
Today's print will test whether the improving analyst sentiment and AUM stabilisation narrative can hold up against the persistent structural headwinds that have kept most of the Street at hold-equivalent ratings.
See the live data behind this article on ORTEX.
Open BEN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
